financetom
Business
financetom
/
Business
/
Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race
Nov 13, 2025 3:13 PM

Nov 13 (Reuters) - Mikael Dolsten, Pfizer's ( PFE )

former research and development chief, has withdrawn his

candidacy for Novo Nordisk's board, the Danish

drugmaker said on Thursday, citing personal reasons.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved